Brenig Therapeutics, Inc. (Brenig), a clinical-stage biotechnology company advancing small-molecule therapies for neurologic diseases, today announced that Tien Dam, MD, Chief Medical Officer, will ...

A new survey reveals a shocking trend: bosses are firing Gen Z graduates at high rates. Discover the top reasons for this workplace clash and what it means for the future.

The board also warned that attempts to spread rumours or misrepresent facts about the evaluation process could be treated as ...

Columbia Dividend Income Fund outperformed its benchmark in Q4 2025 with a 2.48% return. Read the full analysis for more details.